Emmanuel J. Sablan

Publications

123

Citations

H-Index

2010

Active since

Affiliations

Amplyx Pharmaceuticals (United States)(Current)

Emmanuel J. Sablan is an author at Amplyx Pharmaceuticals (United States) specializing in health sciences, diabetes, and gastrointestinal pharmacology.

Top concepts

HealthDiabetesMedicinePhysiologyPharmacologyEndocrinologyMetabolic SyndromeGastrointestinal PharmacologyPathologyImmunology

Publications per year

2010–2014

Publications

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

Krystyna Tatarkiewicz, Pam Smith, Emmanuel J. Sablan et al. · American Journal of Physiology-Endocrinology and Metabolism · 2010 · 91 citations · Full text

Gastrointestinal Pharmacology, Immunology, Gastroenterology +17

Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor

Krystyna Tatarkiewicz, Emmanuel J. Sablan, Clara J. Polizzi et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2014 · 32 citations

Gastrointestinal Pharmacology, Food Intake, Insulin Signaling +18

Rows per page

1–2 of 2